Table 3.

HR (95% CI) for Heart Failure Hospitalization and Death by Pulmonary Hypertension Status in the Jackson Heart Study

Outcome	Events N (%)	Crude		Model 1*		Model 2†
		HR (95% CI)	P-value	HR (95% CI)	P-value	HR (95% CI)	P-value
Heart failure hospitalization‡
• No pulmonary hypertension	24 (10)	1.0 (ref)	—	1.0 (ref)	—	1.0 (ref)	—
• Pulmonary hypertension present	16 (27)	3.19 (1.70, 6.02)	<0.001	2.90 (1.45, 5.81)	0.003	2.37 (1.15, 4.86)	0.0189
Death
• No pulmonary hypertension	70 (22)	1.0 (ref)	—	1.0 (ref)	—	1.0 (ref)	—
• Pulmonary hypertension present	39 (44)	2.39 (1.62, 3.54)	<0.001	1.83 (1.21, 2.76)	0.004	1.37 (0.89, 2.13)	0.16

^*Model 1 adjusted for age, sex, diabetes mellitus, estimated glomerular filtration rate, and ejection fraction.

^†Model 2 adjusted for b-type natriuretic peptide in addition to covariates in model 1.

^‡Because of missing data on heart failure hospitalization (N=106), the total N for this analysis is 302 (242 in the no PH group and 60 in the PH group). Please see method sections for more details.

HR, hazard ratio; CI, confidence interval.